Molecular Targeted Diagnostics Market, By Product, By Application, By Technology, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
Description
REPORT HIGHLIGHT
Molecular Targeted Diagnostics Market size was valued at USD 15,408.33 Million in 2023, expanding at a CAGR of 7.02% from 2024 to 2032.
Molecular targeted diagnostics focuses on identifying specific molecular markers in a patient's body usually in cells, tissues, or bodily fluids. These molecular markers often include DNA, RNA, proteins, and other biomolecules. The primary purpose is to detect abnormalities at the molecular level that may be indicative of diseases such as cancer, cardiovascular disorders, or genetic conditions.
Molecular Targeted Diagnostics Market- Market Dynamics
Increasing prevalence of cancer and the need for early & accurate detection, screening is expected to propel market demand
The rising global incidence of cancer has led to an increased need for diagnostic methods that can detect cancers early and accurately. Molecular diagnostics provide valuable insights into the genetic alterations that drive tumor growth, leading to better outcomes with targeted therapies. The growing awareness of genetic disorders and rare diseases, as well as the need for early and accurate detection, is increasing the demand for molecular targeted diagnostics, thereby boosting market growth. These tests help in identifying hereditary conditions and assist in prenatal screening and newborn testing.
Growing awareness of early diagnosis and screening in preventing disease progression is driving the demand for molecular targeted diagnostics. Public health initiatives are promoting the adoption of screening programs for cancer, genetic disorders, and infectious diseases. The molecular targeted diagnostics market is experiencing significant growth due to advancements in personalized medicine, the increasing prevalence of cancer and genetic diseases, technological innovations, and the expanding use of non-invasive diagnostic techniques like liquid biopsy.
Molecular Targeted Diagnostics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.02% over the forecast period (2024-2032)
Based on Product segmentation, the reagents segment was predicted to show maximum market share in the year 2023, owing to high adoption in clinics & research industry.
Based on Application segmentation, infectious diseases segment was the leading Application segment in 2023, due to the growing prevalence of infectious & viral disorders.
Based on Technology segmentation, polymerase chain reaction (PCR) segment was the leading Technology segment in 2023, due to high demand for treating infectious diseases.
On the basis of region, North America was the leading revenue generator in 2023, due to the supportive government initiatives in new drugs development.
Molecular Targeted Diagnostics Market- Segmentation Analysis:
The Global Molecular Targeted Diagnostics Market is segmented on the basis of Product, Application, Technology, and Region.
The market is divided into three categories based on Product: instruments, reagents, and others. The reagents segment dominates the market. The increasing adoption of novel tests and growing research activities is fostering market growth.
The market is divided into six categories based on Application: infectious diseases, pharmacogenomics, oncology, genetic testing, microbiology, and others. The infectious diseases segment dominates the market. The molecular diagnosis is effective & vital in infectious disorders cure which is the main factor increasing market growth.
The market is divided into five categories based on Technology: PCR, chips & microarrays, mass spectrometry, sequencing, and others. The PCR segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing emergence during COVID-19 and other infectious diseases have fueled the demand for molecular diagnostics demand.
Molecular Targeted Diagnostics Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is witnessing significant growth, driven by increasing healthcare investments, rising cancer incidences, and greater adoption of advanced diagnostics. China is a major driver in the region, with a rapidly growing precision medicine market, government support for genetic research, and an increasing prevalence of cancer. Europe is another significant player in the molecular targeted diagnostics market, led by countries like Germany, the U.K., and France. The U.S. leads in innovation, with numerous clinical trials and approvals of companion diagnostics.
Molecular Targeted Diagnostics Market- Competitive Landscape:
The Molecular Targeted Diagnostics market is highly competitive and features numerous established players and innovative startups. The competition is driven by advancements in technology, partnerships, and the rising demand for precision medicines. Companies are focused on obtaining regulatory approvals for companion diagnostics, particularly in the U.S. and Europe. Expanding into emerging markets, such as Asia-Pacific and Latin America, is also a key growth strategy for many firms. Several companies are forming partnerships with pharmaceutical firms to co-develop companion diagnostics. This trend is particularly strong in oncology, where companies like Roche, Qiagen, and Thermo Fisher are leading the development of diagnostics for targeted cancer therapies.
In July 2024, Thermo Fisher Scientific completed the acquisition of Olink Holdings AB to expand their reach across Europe.
In 2022, Illumina Inc., has developed several cancer-focused panels, including the TruSight Oncology 500, which is used for comprehensive genomic profiling.
In 2021, Roche acquired GenMark Diagnostics, expanding its portfolio in multiplex molecular diagnostics.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET KEY PLAYERS
Thermo Fisher Scientific
Qiagen N.V.
Abbott Laboratories
Illumina, Inc.
Agilent Technologies
Bio-Rad Laboratories
Becton, Dickinson and Company (BD)
Hologic, Inc.
Myriad Genetics, Inc.
Siemens Healthineers
Danaher Corporation
Genomic Health
Sysmex Corporation
Grifols SA
bioMerieux SA
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032
Instruments
Reagents
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Infectious diseases
Pharmacogenomics
Oncology
Genetic testing
Microbiology
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032
PCR
Chips & microarrays
Mass spectrometry
Sequencing
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Molecular Targeted Diagnostics Market size was valued at USD 15,408.33 Million in 2023, expanding at a CAGR of 7.02% from 2024 to 2032.
Molecular targeted diagnostics focuses on identifying specific molecular markers in a patient's body usually in cells, tissues, or bodily fluids. These molecular markers often include DNA, RNA, proteins, and other biomolecules. The primary purpose is to detect abnormalities at the molecular level that may be indicative of diseases such as cancer, cardiovascular disorders, or genetic conditions.
Molecular Targeted Diagnostics Market- Market Dynamics
Increasing prevalence of cancer and the need for early & accurate detection, screening is expected to propel market demand
The rising global incidence of cancer has led to an increased need for diagnostic methods that can detect cancers early and accurately. Molecular diagnostics provide valuable insights into the genetic alterations that drive tumor growth, leading to better outcomes with targeted therapies. The growing awareness of genetic disorders and rare diseases, as well as the need for early and accurate detection, is increasing the demand for molecular targeted diagnostics, thereby boosting market growth. These tests help in identifying hereditary conditions and assist in prenatal screening and newborn testing.
Growing awareness of early diagnosis and screening in preventing disease progression is driving the demand for molecular targeted diagnostics. Public health initiatives are promoting the adoption of screening programs for cancer, genetic disorders, and infectious diseases. The molecular targeted diagnostics market is experiencing significant growth due to advancements in personalized medicine, the increasing prevalence of cancer and genetic diseases, technological innovations, and the expanding use of non-invasive diagnostic techniques like liquid biopsy.
Molecular Targeted Diagnostics Market- Key Insights
As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.02% over the forecast period (2024-2032)
Based on Product segmentation, the reagents segment was predicted to show maximum market share in the year 2023, owing to high adoption in clinics & research industry.
Based on Application segmentation, infectious diseases segment was the leading Application segment in 2023, due to the growing prevalence of infectious & viral disorders.
Based on Technology segmentation, polymerase chain reaction (PCR) segment was the leading Technology segment in 2023, due to high demand for treating infectious diseases.
On the basis of region, North America was the leading revenue generator in 2023, due to the supportive government initiatives in new drugs development.
Molecular Targeted Diagnostics Market- Segmentation Analysis:
The Global Molecular Targeted Diagnostics Market is segmented on the basis of Product, Application, Technology, and Region.
The market is divided into three categories based on Product: instruments, reagents, and others. The reagents segment dominates the market. The increasing adoption of novel tests and growing research activities is fostering market growth.
The market is divided into six categories based on Application: infectious diseases, pharmacogenomics, oncology, genetic testing, microbiology, and others. The infectious diseases segment dominates the market. The molecular diagnosis is effective & vital in infectious disorders cure which is the main factor increasing market growth.
The market is divided into five categories based on Technology: PCR, chips & microarrays, mass spectrometry, sequencing, and others. The PCR segment dominates the market and is expected to maintain its high dominance during the forecast period. The growing emergence during COVID-19 and other infectious diseases have fueled the demand for molecular diagnostics demand.
Molecular Targeted Diagnostics Market- Geographical Insights
Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is witnessing significant growth, driven by increasing healthcare investments, rising cancer incidences, and greater adoption of advanced diagnostics. China is a major driver in the region, with a rapidly growing precision medicine market, government support for genetic research, and an increasing prevalence of cancer. Europe is another significant player in the molecular targeted diagnostics market, led by countries like Germany, the U.K., and France. The U.S. leads in innovation, with numerous clinical trials and approvals of companion diagnostics.
Molecular Targeted Diagnostics Market- Competitive Landscape:
The Molecular Targeted Diagnostics market is highly competitive and features numerous established players and innovative startups. The competition is driven by advancements in technology, partnerships, and the rising demand for precision medicines. Companies are focused on obtaining regulatory approvals for companion diagnostics, particularly in the U.S. and Europe. Expanding into emerging markets, such as Asia-Pacific and Latin America, is also a key growth strategy for many firms. Several companies are forming partnerships with pharmaceutical firms to co-develop companion diagnostics. This trend is particularly strong in oncology, where companies like Roche, Qiagen, and Thermo Fisher are leading the development of diagnostics for targeted cancer therapies.
In July 2024, Thermo Fisher Scientific completed the acquisition of Olink Holdings AB to expand their reach across Europe.
In 2022, Illumina Inc., has developed several cancer-focused panels, including the TruSight Oncology 500, which is used for comprehensive genomic profiling.
In 2021, Roche acquired GenMark Diagnostics, expanding its portfolio in multiplex molecular diagnostics.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET KEY PLAYERS
Thermo Fisher Scientific
Qiagen N.V.
Abbott Laboratories
Illumina, Inc.
Agilent Technologies
Bio-Rad Laboratories
Becton, Dickinson and Company (BD)
Hologic, Inc.
Myriad Genetics, Inc.
Siemens Healthineers
Danaher Corporation
Genomic Health
Sysmex Corporation
Grifols SA
bioMerieux SA
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032
Instruments
Reagents
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032
Infectious diseases
Pharmacogenomics
Oncology
Genetic testing
Microbiology
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019-2032
PCR
Chips & microarrays
Mass spectrometry
Sequencing
Others
GLOBAL MOLECULAR TARGETED DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019-2032
North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA
Table of Contents
260 Pages
- 1. Molecular Targeted Diagnostics Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
- 2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Molecular Targeted Diagnostics Market Snippet by Product
- 2.1.2. Molecular Targeted Diagnostics Market Snippet by Application
- 2.1.3. Molecular Targeted Diagnostics Market Snippet by Technology
- 2.1.4. Molecular Targeted Diagnostics Market Snippet by Country
- 2.1.5. Molecular Targeted Diagnostics Market Snippet by Region
- 2.2. Competitive Insights
- 3. Molecular Targeted Diagnostics Key Market Trends
- 3.1. Molecular Targeted Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Molecular Targeted Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Molecular Targeted Diagnostics Market Opportunities
- 3.4. Molecular Targeted Diagnostics Market Future Trends
- 4. Molecular Targeted Diagnostics Industry Study
- 4.1. PEST Analysis
- 4.2. Porter’s Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
- 5. Molecular Targeted Diagnostics Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
- 6. Molecular Targeted Diagnostics Market Landscape
- 6.1. Molecular Targeted Diagnostics Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players’ Analysis
- 6.2.2. Emerging Players’ Analysis
- 7. Molecular Targeted Diagnostics Market – By Product
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
- 7.1.2. Instruments
- 7.1.3. Reagents
- 7.1.4. Others
- 8. Molecular Targeted Diagnostics Market – By Application
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 8.1.2. Infectious diseases
- 8.1.3. Pharmacogenomics
- 8.1.4. Oncology
- 8.1.5. Genetic testing
- 8.1.6. Microbiology
- 8.1.7. Others
- 9. Molecular Targeted Diagnostics Market – By Technology
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Technology, 2024 & 2032 (%)
- 9.1.2. PCR
- 9.1.3. Chips & microarrays
- 9.1.4. Mass spectrometry
- 9.1.5. Sequencing
- 9.1.6. Others
- 10. Molecular Targeted Diagnostics Market– By Geography
- 10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
- 10.2. North America
- 10.2.1. Overview
- 10.2.2. Molecular Targeted Diagnostics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.7. U.S.
- 10.2.7.1. Overview
- 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.7.5. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.2.8. Canada
- 10.2.8.1. Overview
- 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.2.8.5. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3. Europe
- 10.3.1. Overview
- 10.3.2. Molecular Targeted Diagnostics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.7. Germany
- 10.3.7.1. Overview
- 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.7.5. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.8. Italy
- 10.3.8.1. Overview
- 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.8.5. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.9. United Kingdom
- 10.3.9.1. Overview
- 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.9.5. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.10. France
- 10.3.10.1. Overview
- 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.10.5. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.11. Russia
- 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.11.4. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.12. Netherlands
- 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.12.4. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.13. Sweden
- 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.13.4. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.14. Poland
- 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.14.4. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.3.15. Rest of Europe
- 10.3.15.1. Overview
- 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.3.15.5. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Molecular Targeted Diagnostics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.7. India
- 10.4.7.1. Overview
- 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.7.5. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.8. China
- 10.4.8.1. Overview
- 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.8.5. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.9. Japan
- 10.4.9.1. Overview
- 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.9.5. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.10. South Korea
- 10.4.10.1. Overview
- 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.10.5. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.11. Australia
- 10.4.11.1. Overview
- 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.11.5. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.12. Thailand
- 10.4.12.1. Overview
- 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.12.5. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.13. Indonesia
- 10.4.13.1. Overview
- 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.13.5. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.14. Philippines
- 10.4.14.1. Overview
- 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.14.5. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.4.15. Rest of APAC
- 10.4.15.1. Overview
- 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.4.15.5. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Molecular Targeted Diagnostics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.7. Brazil
- 10.5.7.1. Overview
- 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.7.5. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.8. Mexico
- 10.5.8.1. Overview
- 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.8.5. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.9. Argentina
- 10.5.9.1. Overview
- 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.9.5. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.10. Colombia
- 10.5.10.1. Overview
- 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.10.5. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.5.11. Rest of LATAM
- 10.5.11.1. Overview
- 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.5.11.5. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Molecular Targeted Diagnostics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.7. Saudi Arabia
- 10.6.7.1. Overview
- 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.7.5. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.8. United Arab Emirates
- 10.6.8.1. Overview
- 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.8.5. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.9. Israel
- 10.6.9.1. Overview
- 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.9.5. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.10. Turkey
- 10.6.10.1. Overview
- 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.10.5. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.11. Algeria
- 10.6.11.1. Overview
- 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.11.5. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.12. Egypt
- 10.6.12.1. Overview
- 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.12.5. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 10.6.13. Rest of MEA
- 10.6.13.1. Overview
- 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
- 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 10.6.13.5. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
- 11. Key Vendor Analysis- Molecular Targeted Diagnostics Industry
- 11.1. Competitive Dashboard
- 11.2. Company Profiles
- 11.2.1. Thermo Fisher Scientific
- 11.2.2. Qiagen N.V.
- 11.2.3. Abbott Laboratories
- 11.2.4. Illumina, Inc.
- 11.2.5. Agilent Technologies
- 11.2.6. Bio-Rad Laboratories
- 11.2.7. Becton, Dickinson and Company (BD)
- 11.2.8. Hologic, Inc.
- 11.2.9. Myriad Genetics, Inc.
- 11.2.10. Siemens Healthineers
- 11.2.11. Danaher Corporation
- 11.2.12. Genomic Health
- 11.2.13. Sysmex Corporation
- 11.2.14. Grifols SA
- 11.2.15. bioMerieux SA
- 11.2.16. Others
- 12. 360 Degree Analyst View
- 13. Appendix
- 13.1. Research Methodology
- 13.2. References
- 13.3. Abbreviations
- 13.4. Disclaimer
- 13.5. Contact Us
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
